Bovine Congenital Erythropoietic Protoporphyria in Cows

Bovine congenital erythropoietic protoporphyria, often shortened to BCEPP, is a rare inherited metabolic disease in cattle. It happens when protoporphyrin builds up because the body cannot complete a normal step in heme production. That buildup makes the skin highly reactive to sunlight, so affected cattle can develop painful photosensitization and skin damage after light exposure.

This condition is different from some other bovine porphyrias. In BCEPP, the main problem is usually severe photodermatitis, not the pink or brown tooth discoloration classically described with other porphyrin disorders. Published reports and veterinary references describe BCEPP most often in Limousin and Blonde d'Aquitaine cattle, although crossbred animals can also be affected.

For pet parents and producers, the practical takeaway is that this is usually a lifelong genetic condition, not an infection and not something one animal “catches” from another. Management is aimed at reducing sun-triggered skin injury, keeping the animal comfortable, and making careful breeding decisions with your vet and herd advisors.

BCEPP is caused by an inherited defect in the ferrochelatase enzyme, the last step in heme synthesis. When ferrochelatase does not work normally, protoporphyrin accumulates in the body instead of being converted efficiently into heme. Protoporphyrin is highly photoreactive, so sunlight exposure can trigger inflammation and tissue injury in the skin.

This is considered a heritable genetic disorder rather than a nutritional problem or contagious disease. OMIA lists bovine erythropoietic protoporphyria as an autosomal single-gene disorder associated with the FECH gene. Historically, the condition has been documented in Limousin and Blonde d'Aquitaine cattle, and line breeding can increase the chance that affected calves appear.

Because the disease is genetic, the “cause” in an individual animal is present from birth even if signs become more obvious later with pasture turnout and sun exposure. Your vet may also discuss the difference between this congenital disorder and secondary photosensitization, which is much more common and can happen with liver disease or certain plants.

Diagnosis starts with a history and physical exam. Your vet will look at the pattern of lesions, age of onset, breed background, pasture exposure, and whether the problem recurs with sunlight. Because BCEPP is uncommon, the first step is often ruling out more common causes of photosensitization such as hepatogenous photosensitivity, toxic plants, parasites, or severe sunburn in unpigmented skin.

Initial testing may include a farm call exam, skin evaluation, and basic lab work such as a CBC and chemistry panel to look for evidence of liver disease or other systemic illness. In published reports of BCEPP, routine bloodwork may be within reference ranges, which can help steer the workup away from liver-related photosensitization.

Definitive diagnosis is usually based on genetic testing for the inherited defect, supported by the clinical picture. Your vet may also recommend skin biopsy or, in some cases, necropsy and laboratory confirmation if the diagnosis remains uncertain. If one calf is affected, herd-level discussion matters, because identifying carriers and avoiding repeat matings can help prevent future cases.

Because BCEPP is an inherited disorder, prevention focuses on breeding management, not vaccines or feed changes. The most important step is to avoid breeding affected animals and to work with your vet, breed association, and laboratory resources if carrier testing is available for your herd line. Merck specifically notes that selective breeding can reduce disease incidence by decreasing the use of carrier animals.

If a calf is diagnosed or strongly suspected to have BCEPP, review the pedigree and discuss whether related animals should be flagged before future matings. This matters most in herds using line breeding or repeat pairings that may concentrate recessive defects.

For animals already affected, prevention of flare-ups means reducing sun exposure as much as possible. Shade, indoor housing during peak daylight, and close monitoring of exposed skin can lower the risk of severe lesions. These steps do not prevent the genetic disease itself, but they can help prevent repeated skin injury and improve day-to-day comfort.